We are live on
!
Find out more
MC
Maverick Capital Portfolio holdings
AUM
$8.67B
1-Year Est. Return
48.76%
This Fund
S&P 500
This Quarter
Est. Return
-2.93%
1 Year Est. Return
+48.76%
3 Year Est. Return
+198.74%
5 Year Est. Return
+110.99%
10 Year Est. Return
+397.6%
AUM
$10.6B
AUM Growth
-$205M
(-1.9%)
Cap. Flow
+$74.8M
Cap. Flow
% of AUM
0.7%
Top 10 Holdings %
Top 10 Hldgs %
60.06%
Holding
915
New
227
Increased
218
Reduced
210
Closed
254
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$234M |
| 2 |
Jones Lang LaSalle
JLL
|
+$172M |
| 3 |
CANO
Cano Health, Inc.
CANO
|
+$113M |
| 4 |
Carvana
CVNA
|
+$84.7M |
| 5 |
IS
ironSource Ltd.
IS
|
+$64.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$89.8M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$73.8M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$73.3M |
| 4 |
Lam Research
LRCX
|
+$73M |
| 5 |
Amazon
AMZN
|
+$71.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 52.75% |
| 2 | Healthcare | 14.85% |
| 3 | Technology | 11.17% |
| 4 | Communication Services | 7.75% |
| 5 | Financials | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Roper Technologies
ROP
$38.5B
| $547K | 0.01% |
1,164
+964
| +482% | +$426K |
|
377
BioMarin Pharmaceuticals
BMRN
$11.7B
| $541K | 0.01% |
+6,480
| New | +$514K |
|
378
Truist Financial
TFC
$63.5B
| $541K | 0.01% |
+9,744
| New | +$572K |
|
379
Dolby
DLB
$4.9B
| $539K | 0.01% |
5,485
+461
| +9% | +$45.5K |
|
380
Alkermes
ALKS
$8.39B
| $535K | 0.01% |
21,836
-10,222
| -32% | -$227K |
|
381
Western Digital
WDC
$184B
| $534K | 0.01% |
+9,924
| New | +$537K |
|
382
Intuitive Surgical
ISRG
$126B
| $533K | 0.01% |
1,740
-10,746
| -86% | -$3.01M |
|
383
IPG Photonics
IPGP
$3.6B
| $528K | 0.01% |
2,505
-1,257
| -33% | -$265K |
|
384
Keysight
KEYS
$53.4B
| $526K | ﹤0.01% |
3,408
-1,552
| -31% | -$225K |
|
385
Revvity
RVTY
$12.7B
| $522K | ﹤0.01% |
+3,381
| New | +$475K |
|
386
Stryker
SYK
$133B
| $516K | ﹤0.01% |
1,987
-6,043
| -75% | -$1.55M |
|
387
Chegg
CHGG
$118M
| $511K | ﹤0.01% |
+6,143
| New | +$509K |
|
388
Fox Class A
FOXA
$24.7B
| $511K | ﹤0.01% |
13,755
-1,206
| -8% | -$45.3K |
|
389
Pinterest
PINS
$13.7B
| $502K | ﹤0.01% |
+6,353
| New | +$443K |
|
|
AYX
390
DELISTED
Alteryx Inc
AYX
| $501K | ﹤0.01% |
+5,819
| New | +$476K |
|
391
MetLife
MET
$62.5B
| $496K | ﹤0.01% |
+8,289
| New | +$525K |
|
392
Medifast
MED
$110M
| $495K | ﹤0.01% |
1,750
-3,490
| -67% | -$946K |
|
393
IDEX
IEX
$17.3B
| $478K | ﹤0.01% |
+2,172
| New | +$480K |
|
|
GES
394
DELISTED
Guess Inc
GES
| $470K | ﹤0.01% |
17,817
-40,350
| -69% | -$1.11M |
|
|
CSII
395
DELISTED
Cardiovascular Systems, Inc.
CSII
| $457K | ﹤0.01% |
+10,716
| New | +$419K |
|
|
BHVN
396
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $446K | ﹤0.01% |
+4,594
| New | +$373K |
|
397
Teva Pharmaceuticals
TEVA
$41.2B
| $444K | ﹤0.01% |
44,879
-110,962
| -71% | -$1.17M |
|
398
Thermo Fisher Scientific
TMO
$214B
| $442K | ﹤0.01% |
876
-1,519
| -63% | -$717K |
|
399
KALA BIO
KALA
$13.6M
| $433K | ﹤0.01% |
+33
| New | +$519K |
|
400
Cheniere Energy
LNG
$54.1B
| $430K | ﹤0.01% |
4,961
+4,011
| +422% | +$326K |
|
Similar funds
PCIA
ACM
OAM
NB
IC
SWP
MOACM
MERSOM
Maverick Capital's Q2 2021 Portfolio in Review
As of Q2 2021, Maverick Capital held 915 positions worth $10.6B, down 1.9% from $10.9B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Maverick Capital's Q2 2021 filing shows 227 new, 218 increased, 210 reduced and 254 closed positions. Its largest new stake was Centene: 3,416,815 shares worth $249M. The largest sale was Applied Materials, an estimated $89.8M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 53% of assets, down from 55% a quarter earlier, followed by Healthcare and Technology.
- Maverick Capital's largest Q2 2021 buy was Centene: 3,416,815 shares worth $249M.
- Maverick Capital added most to Carvana in Q2 2021, an estimated $84.7M increase.
- Maverick Capital's biggest Q2 2021 reduction was Applied Materials, cutting an estimated $89.8M.
- Maverick Capital fully exited Fidelity National Information Services in Q2 2021, selling an estimated $63.1M.
- Maverick Capital's ten largest holdings make up 60% of its $10.6B portfolio in Q2 2021.
- Maverick Capital opened 227 new positions and closed 254 in Q2 2021.
- Maverick Capital's portfolio value fell 1.9% quarter-over-quarter to $10.6B.
Based on Maverick Capital's 13F filing for Q2 2021, filed 16 Aug 2021.